Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human CXCL14/BRAK Alexa Fluor Plus 647-conjugated Antibody, R&D Systems™
SDP

Catalog No. RD10104925
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
RD10104925 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. RD10104925 Supplier R&D Systems Supplier No. AF866AFP647100UG

Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

Goat Polyclonal Antibody

CXCL14/BRAK Polyclonal antibody specifically detects CXCL14/BRAK in Human samples. It is validated for Western Blot

Specifications

Antigen CXCL14/BRAK
Applications Western Blot
Classification Polyclonal
Conjugate Alexa Fluor Plus 647
Formulation Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
Gene Alias BMAC, Bolekine, BRAK, BRAKKEC, chemokine (C-X-C motif) ligand 14, Chemokine BRAK, CXC-X3, member 14 (BRAK), MIP-2 gamma, MIP2G, MIP-2G, NJACKec, SCYB14MGC10687, Small-inducible cytokine B14
Host Species Goat
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 9547
Target Species Human
Content And Storage Protect from light. Do not freeze. 12 months from date of receipt, 2°C to 8°C as supplied
Product Type Antibody
Form Liquid
Isotype IgG
Product Line R&D Systems
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.